99 related articles for article (PubMed ID: 6236861)
41. [Observation on urinary glycosaminoglycan excretion in patients with urinary calculus in relation to the nature of organic matrix of calculi].
Baba S; Nakazawa K; Odajima K; Fujioka T; Nakamura H
Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):608-15. PubMed ID: 6413740
[No Abstract] [Full Text] [Related]
42. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS
Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363
[TBL] [Abstract][Full Text] [Related]
43. Beta-glucuronidase deficiency (mucopolysaccharidosis type VII).
Beaudet AL; Ferrante NM; Ferry GD; Nichols BL
Birth Defects Orig Artic Ser; 1974; 10(12):246-50. PubMed ID: 4218769
[No Abstract] [Full Text] [Related]
44. [Mucopolysaccharidosis I, Hurler syndrome: a case report].
Amorín M; Carlin A; Prötzel A
Arch Argent Pediatr; 2012 Oct; 110(5):e103-6. PubMed ID: 23070190
[TBL] [Abstract][Full Text] [Related]
45. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.
Kuiper GA; van Hasselt PM; Boelens JJ; Wijburg FA; Langereis EJ
Mol Genet Metab; 2017 Sep; 122(1-2):86-91. PubMed ID: 28684085
[TBL] [Abstract][Full Text] [Related]
46. Sinus complications in mucopolysaccharidosis IH/S (Hurler-Scheie syndrome).
MacArthur CJ; Gliklich R; McGill TJ; Perez-Atayde A
Int J Pediatr Otorhinolaryngol; 1993 Feb; 26(1):79-87. PubMed ID: 8444549
[TBL] [Abstract][Full Text] [Related]
47. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
48. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
Toma L; Dietrich CP; Nader HB
Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
[TBL] [Abstract][Full Text] [Related]
49. Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine.
Sakai S; Onose J; Nakamura H; Toyoda H; Toida T; Imanari T; Linhardt RJ
Anal Biochem; 2002 Mar; 302(2):169-74. PubMed ID: 11878794
[TBL] [Abstract][Full Text] [Related]
50. Fluorometric measurement of urinary alpha-L-iduronidase activity.
Isemura M; Kosaka H; Ikenaka T; Kido R; Yoshimura T
J Biochem; 1978 Sep; 84(3):627-32. PubMed ID: 102641
[TBL] [Abstract][Full Text] [Related]
51. Mutation c.1190-1delG/N in intron 8 and c.1708G>C/N in exon 12 not reported in the IDUA gene developed a clinical phenotype of Scheie syndrome.
Delgado Luengo WN; Miranda Contreras LE; Chávez CJ; Solis-Añez E; Cammarata-Scalisi F
Invest Clin; 2014 Dec; 55(4):365-70. PubMed ID: 25558755
[TBL] [Abstract][Full Text] [Related]
52. Screening study on excretion pattern of urinary glycosaminoglycans from orthopedic patients.
Sato K; Nagatsuka Y; Isemura M; Ototani N; Yosizawa Z
Tohoku J Exp Med; 1982 Jun; 137(2):179-90. PubMed ID: 6810502
[TBL] [Abstract][Full Text] [Related]
53. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
54. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
[TBL] [Abstract][Full Text] [Related]
55. Chondroitin 4- and 6-sulfate mucopolysaccharidosis--a morphological study.
Takahashi K; Yaginuma Y; Kojima M; Hakozaki H; Hoshino R; Hayashi S
Acta Pathol Jpn; 1978 Nov; 28(6):979-93. PubMed ID: 104545
[TBL] [Abstract][Full Text] [Related]
56. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
[TBL] [Abstract][Full Text] [Related]
57. Urinary mucopolysaccharide excretion in the sex-linked form of the Hurler syndrome.
CAMPBELL TN; FRIED M
Proc Soc Exp Biol Med; 1961 Nov; 108():529-33. PubMed ID: 13876066
[No Abstract] [Full Text] [Related]
58. THE HURLER SYNDROME: A BIOCHEMICAL AND CLINICAL STUDY.
BEARN AG
Am J Med; 1965 Aug; 39():221-9. PubMed ID: 14320688
[No Abstract] [Full Text] [Related]
59. Increased urine heparan and chondroitin sulphate excretion in patients with osteopetrosis.
Steiner RD; Whyte MP; Chang E; Hanks J; Mattes C; Senephansiri H; Gibson KM
J Inherit Metab Dis; 2000 Feb; 23(1):88-90. PubMed ID: 10682314
[No Abstract] [Full Text] [Related]
60. Hurler/Scheie genetic compound (mucopolysaccharidosis IH/IS) in Japanese brothers.
Kajii T; Matsuda I; Osawa T; Katsunuma H; Ichida T
Clin Genet; 1974; 6(5):394-400. PubMed ID: 4373197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]